EXPRESSION OF GLOMERULAR EXTRACELLULAR-MATRIX COMPONENTS IN HUMAN DIABETIC NEPHROPATHY - DECREASE OF HEPARAN-SULFATE IN THE GLOMERULAR-BASEMENT-MEMBRANE

被引:176
作者
TAMSMA, JT
VANDENBORN, J
BRUIJN, JA
ASSMANN, KJM
WEENING, JJ
BERDEN, JHM
WIESLANDER, J
SCHRAMA, E
HERMANS, J
VEERKAMP, JH
LEMKES, HHPJ
VANDERWOUDE, FJ
机构
[1] UNIV HOSP LEIDEN,DEPT PATHOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV HOSP LEIDEN,DEPT NEPHROL,2300 RC LEIDEN,NETHERLANDS
[3] UNIV HOSP NIJMEGEN,DEPT NEPHROL,NIJMEGEN,NETHERLANDS
[4] UNIV HOSP NIJMEGEN,DEPT PATHOL,NIJMEGEN,NETHERLANDS
[5] UNIV AMSTERDAM,DEPT PATHOL,AMSTERDAM,NETHERLANDS
[6] STATENS SERUMINST,DEPT AUTOIMMUNE SEROL,COPENHAGEN,DENMARK
[7] LEIDEN UNIV,DEPT MED STAT,2300 RA LEIDEN,NETHERLANDS
[8] UNIV NIJMEGEN,DEPT BIOCHEM,NIJMEGEN,NETHERLANDS
关键词
DIABETIC NEPHROPATHY; HEPARAN SULFATE; HEPARAN SULFATE PROTEOGLYCAN; GLOMERULAR BASEMENT MEMBRANE; EXTRACELLULAR MATRIX;
D O I
10.1007/BF00398060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is characterized by albuminuria which proceeds to overt proteinuria. The highly negatively stained HS side chain of heparan sulphate proteoglycan (HSPG) is a major determinant of the charge-dependent permeability of the GBM. We set out to study the presence of HS and HSPG in the GBM of patients with diabetic nephropathy using newly developed monoclonal antibodies, and to compare HSPG expression to the expression of other previously investigated glomerular extracellular matrix compounds. Immunohistochemically, glomerular extracellular matrix components were analysed in 14 renal biopsies of patients with diabetic nephropathy and compared with those of normal control subjects. Monoclonal antibodies used were: JM403 against the HS side chain of GBM HSPG and JM72 against the HSPG-core protein. Also, a polyclonal antiserum (B31) against human GBM-HSPG-core protein was used. Additionally, antibodies were used against collagen types I, III, IV and against alpha 1(IV)NC, alpha 3(IV)NC and fibronectin. Staining was scored for intensity and for staining pattern by four independent observers who had no previous knowledge of the sample origin. No glomerular staining was seen for collagen type I, Collagen type III was present in some diabetic nodules. Anti-collagen type IV showed a decreased GBM staining in patients with diabetic nephropathy (p = 0.04). With anti-alpha 1(IV)NC no changes in GBM staining intensity were observed; with anti-alpha 3(IV)NC brilliant GBM staining was seen in both groups. Increased mesangial staining (p = 0.003) was seen with anti-collagen type IV in biopsies with nodular lesions. No differences were observed for fibronectin although it was abundantly present in the mesangial area of biopsies from patients with diabetic nephropathy. In biopsies with mesangial expansion and in biopsies with diabetic nodules, we observed a decreased GBM(p = 0.001) HS side chain staining (JM403) without changes in HSPG-core protein staining (JM72,B31). The HS staining pattern regularly changed from a linear to a more granular and irregular pattern. In patients with a creatinine clearance of more than 15 ml/min, the intensity of GBM HS staining showed an inverse correlation with the rate of proteinuria (r = -0.85, p = 0.004), suggesting a functional relationship. The decreased HS staining in the GBM may reflect the potentially disrupted charge barrier in diabetic nephropathy.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 40 条
  • [1] PHENOTYPIC-EXPRESSION OF COLLAGEN TYPES IN MESANGIAL MATRIX OF DIABETIC AND NONDIABETIC RATS
    ABRASS, CK
    PETERSON, CV
    RAUGI, GJ
    [J]. DIABETES, 1988, 37 (12) : 1695 - 1702
  • [2] BERGIJK EC, 1992, AM J PATHOL, V140, P1147
  • [3] S-35-LABELED GLYCOSAMINOGLYCAN AND S-35-LABELED GLYCOPEPTIDE METABOLISM BY DIABETIC GLOMERULI AND AORTA
    BROWN, DM
    KLEIN, DJ
    MICHAEL, AF
    OEGEMA, TR
    [J]. DIABETES, 1982, 31 (05) : 418 - 425
  • [4] BROWNLEE M, 1990, DIABETES MELLITUS TH, P279
  • [5] CASTELLOT JJ, 1985, AM J PATHOL, V120, P427
  • [6] COHEN MP, 1981, J LAB CLIN MED, V98, P715
  • [7] ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS
    DECKERT, T
    FELDTRASMUSSEN, B
    BORCHJOHNSEN, K
    JENSEN, T
    KOFOEDENEVOLDSEN, A
    [J]. DIABETOLOGIA, 1989, 32 (04) : 219 - 226
  • [8] DECKERT T, 1984, DIABETIC NEPHROPATHY, V3, P83
  • [9] EDGE ASB, 1990, J BIOL CHEM, V265, P15874
  • [10] FAJANS SS, 1990, DIABETES MELLITUS TH, P346